AI-VISION Study Launched to Improve Precision Therapy in Breast Cancer
Researchers from ICR, the Royal Marsden, and experts from the University of Durham and Concr are launching an AI-based clinical study to improve precision therapy in breast cancer. The AI-VISION study will profile tissue samples from patients with triple-negative breast cancer to define and validate biomarkers of chemotherapy response. This two-year study, funded by Innovate UK, aims to deliver precision medicine and improve clinical decision-making for cancer patients.
BC Cancer Centre at Royal Inland Hospital Approved
The Government of British Columbia has approved the business plan for the BC Cancer Centre at Royal Inland Hospital (RIH) in Kamloops, B.C. The $359 million project will include a five-storey facility with state-of-the-art cancer treatment capacity, including radiation therapy, MRI suite, and linear accelerator vaults. The facility will also feature a sacred space for traditional ceremonies in collaboration with Indigenous partners, and a new 470-stall parkade. BC Cancer executive vice-president and chief medical officer Dr. Kim Chi expressed excitement for the new treatment options to be brought to the region.
DELFI Diagnostics Announces Availability of Fragmentome-Based Cancer Monitoring Assay and Collaboration with Immunocore Holdings plc
DELFI Diagnostics, Inc. has announced the availability of the company’s fragmentome-based research use only (RUO) cancer monitoring assay, offering a highly sensitive, inexpensive means of noninvasive measurement of tumor burden and assessing treatment response and resistance in patients with advanced cancer. The company has also revealed a new research collaboration with Immunocore Holdings plc, focusing on exploring the use of the DELFI-TF cancer monitoring assay as an early predictor of benefit from treatment with ImmTAC-based therapies. DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible and deliver a new way to help detect cancer.
The Importance of Colonoscopies for Men Under 50
Colonoscopies are crucial for early detection of colon cancer, the leading cause of cancer deaths in men under 50. Despite the discomfort of the procedure, it is a non-event and can save lives. The American Cancer Society recommends screening to begin at age 45, as colon cancer is increasing in younger adults.
First UK Patients Receive Innovative mRNA Therapy for Cancer in Global Trial
First UK patients have received an innovative mRNA therapy for cancer known as mRNA-4359, as part of a global trial. The therapy aims to help the body recognize and fight cancer cells by presenting common markers of tumors to the patient’s immune system. The Mobilize trial, conducted in partnership between Imperial College London and Imperial College Healthcare NHS Trust, is evaluating the safety and potential of the therapy in treating melanoma, lung cancer, and other ‘solid tumor’ cancers. Researchers are hopeful that the therapy may lead to a new treatment option for challenging-to-treat cancers if proven to be safe and effective.
Early Signs of Breast Cancer in Dogs: What Pet Owners Need to Know
Learn about the early warning signs of breast cancer in dogs and how to reduce the risk of this disease. Dr. Anna Foreman shares valuable insights into the signs of mammary cancer in dogs and provides guidance on monitoring your pet’s health for potential indicators of the disease.
Optimism Grows Among Cancer Specialists
Cancer specialists are expressing increasing optimism about the prospects of beating the disease, citing significant advances in treatment, diagnosis, and prevention that are contributing to higher survival rates among cancer patients. With the emergence of new treatment methods and technological…
British Indian doctor leading international trial for bowel cancer vaccine
A British Indian doctor, Dr. Tony Dhillon, is leading a groundbreaking international trial of a vaccine aimed at combating bowel cancer. Dr. Dhillon, aged 53, serves as a consultant medical oncologist at the Royal Surrey NHS Hospital Trust and holds…
Test May Be ‘Misguiding’ Breast Cancer Treatment for Black Women
Advertisement Test May Be ‘Misguiding’ Breast Cancer Treatment for Black Women February 1, 2024 Brielle Benyon NewsArticle The 21-gene breast recurrence score may lead clinicians away from prescribing chemotherapy to Black women who could benefit from the therapy. Utilizing a…
Genomic Medicine Revolutionizing Cancer Care with Whole-Genome Sequencing
Genomic medicine is leading a revolution in cancer care, with whole-genome sequencing at its core. This tool can sequence a person’s DNA in its entirety, providing a comprehensive test for potential genetic factors contributing to cancer development. Cancer has become…